DOACs in patients with brain cancers: promising but still a long way to go

Blood Adv. 2023 Jan 24;7(2):283-284. doi: 10.1182/bloodadvances.2022009192.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants*
  • Brain Neoplasms* / drug therapy
  • Humans
  • Warfarin

Substances

  • Anticoagulants
  • Warfarin